-
Clinical Profile of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated With Complement Inhibitors: Results From a Real-World Study
Sep 9, 2025, 16:22 PM -
Impacts of China’s National Price Negotiation on Innovative Cancer Drug Availability and Survival Outcomes: A Retrospective and Modeling Study
Sep 9, 2025, 16:22 PM -
Application and Future Potential of Generative Artificial Intelligence (Gen AI) And Large Language Model (LLM) In Health Economics and Outcomes Research (HEOR)
Sep 9, 2025, 16:22 PM -
Predicting the Maximum Fair Price (MFP) From Medicare Negotiations
Sep 9, 2025, 16:22 PM -
Comprehensive Landscape Assessment of Real-World Databases for HEOR Studies in the Asia-Pacific Region: A Growing Opportunity
Sep 9, 2025, 16:22 PM -
Economic Burden of Diabetic Foot Ulcers (DFU) in Algeria
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Gemcitabine Nabpaclitaxel Combination, Modified FOLFIRINOX, and SIROX As First-Line Therapy for Pancreatic Cancer
Sep 9, 2025, 16:22 PM -
Navigating the MFN Pricing Era: Strategic Imperatives for Biopharma
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Eplerenone For the Management of Heart Failure With Reduced Ejection Fraction (HFrEF) in Italy
Sep 9, 2025, 16:22 PM -
Real-World Insights Into Breast Cancer in the UK: Findings From UK EHR-Derived Data
Sep 9, 2025, 16:22 PM -
Herpes Zoster Hospitalization Rates in Germany: A Retrospective Database Analysis
Sep 9, 2025, 16:22 PM -
Epidemiology and Outcomes in a Linked Cohort of Cancer Pathology and Electronic Medical Records From the PHARMO Data Network
Sep 9, 2025, 16:22 PM -
Reducing the Transmission and Annual Burden of Influenza in the UK With Baloxavir Marboxil: A Cost-Effectiveness Analysis Using Evidence From the CENTERSTONE Trial
Sep 9, 2025, 16:22 PM -
Knowledge and Attitudes Regarding the HPV Vaccine Among Secondary School Students
Sep 9, 2025, 16:22 PM -
Real-World Cost-Utility of Faricimab vs. Current and Future Anti-VEGF Therapies in Patients With Neovascular Age-Related Macular Degeneration in Italy
Sep 9, 2025, 16:22 PM -
Multicriteria Health Technology Assessments for High-Cost Oncology Drugs in Peru: A Cross-Sectional Study of RENETSA Records 2023-2024
Sep 9, 2025, 16:22 PM -
Importance of Decisional Context in the Health Technology Assessment (HTA) of Ultra-Orphan Drugs
Sep 9, 2025, 16:22 PM -
Unseen Burdens of Glycogen Storage Disease Type Ia (GSDIa) Experienced by Patients, Caregivers, and their Healthcare Team
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Healthcare Resource Utilization in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in England: A Retrospective, Observational Cohort Study
Sep 9, 2025, 16:22 PM -
Characterizing Exploratory Endpoints in Early Oncology Trials: Insights From Trial Registry Audit
Sep 9, 2025, 16:22 PM